Sri Monashi Life Sciences Private Limited, a active private limited company, was established on 15 November 2011 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24100TG2011PTC077437. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹3.22 Cr.
It upholds a compliant status. Employing 34 professional, Its leadership includes Sivaram Prasad Golla (Director), Veerla Saithirumal Rao (Director). Past directors included Venkata Phani Chandra Danamaraju, Pandillapalli Venkateswara Rao. It holds ₹12.37 Cr open charges and ₹1.95 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H. No.7-1-638 To 643/1, Flat No.215, Beside Esi Hospital, Sundar Nagar, Errag, Adda, Hyderabad, Telangana, 500038.
U24100TG2011PTC077437
077437
15 November 2011
₹4.00 Cr
₹3.22 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sri Monashi Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sivaram Prasad Golla | Director | 15 Nov 2011 | Current |
| Veerla Saithirumal Rao | Director | 22 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Jun 2017 | Past |
| Pramod Abcsdd | Director | 22 May 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sri Monashi Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.2% decrease. The company also saw a substantial fall in profitability, with a 1119.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 97.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sri Monashi Life Sciences had a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹123,716,898.00
₹19,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2021 | Others | ₹0.64 M | Open |
| 23 Mar 2021 | Hdfc Bank Limited | ₹2.07 M | Open |
| 16 Sep 2020 | Axis Bank Limited | ₹1.20 M | Open |
| 31 Aug 2018 | Hdfc Bank Limited | ₹11.98 Cr | Open |
| 02 Mar 2013 | The Karur Vysya Bank Limited | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Sri Monashi Life Sciences has a workforce of 34 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sri Monashi Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Monashi Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sri Monashi Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Sri Monashi Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on Veerla Saithirumal Rao was appointed as a Director was appointed as a Director on 22 May 2023 & has been associated with this company since 2 years 6 months . was documented.
A charge with Hdfc Bank Limited of Rs. 11.98 Cr registered on 31 Aug 2018 with Charge ID 100204233 was modified on 22 May 2022. was recorded as a recent event.
A charge with Others amounted to Rs. 0.06 Cr with Charge ID 100448972 was registered on 20 May 2021. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 100429970 was registered on 23 Mar 2021. was documented.
The CIN of Sri Monashi Life Sciences Private Limited is U24100TG2011PTC077437.
Sri Monashi Life Sciences Private Limited is headquartered at H. No.7-1-638 To 643/1, Flat No.215, Beside Esi Hospital, Sundar Nagar, Errag, Adda, Hyderabad, Telangana, 500038.
Sri Monashi Life Sciences Private Limited was incorporated on 15 November 2011.
The current directors of Sri Monashi Life Sciences Private Limited are
The primary industry of Sri Monashi Life Sciences Private Limited is Manufacturing.
Sri Monashi Life Sciences Private Limited is unlisted.
The authorized capital of Sri Monashi Life Sciences Private Limited is ₹4.00 Cr, and the paid-up capital is ₹3.22 Cr.
The compliance status of Sri Monashi Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX